Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series

被引:24
作者
Armour, Sarah [1 ]
Armour, Trygve K. [1 ]
Joppa, William R. [2 ]
Maltais, Simon [3 ]
Nelson, James A. [1 ]
Wittwer, Erica [1 ]
机构
[1] Mayo Clin, Coll Med & Sci, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med & Sci, Cardiovasc ICU, Rochester, MN USA
[3] Mayo Clin, Coll Med & Sci, Dept Cardiovasc Surg, Rochester, MN USA
关键词
HIGH-DOSE HYDROXOCOBALAMIN; VASOPLEGIC SYNDROME; METHYLENE-BLUE; NITRIC-OXIDE;
D O I
10.1213/ANE.0000000000003648
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Hydroxocobalamin (vitamin B12a) is an emerging treatment for vasoplegic syndrome (VS) associated with cardiopulmonary bypass (CPB). Given its cost and scarcity, an institutional guideline for its use as a rescue treatment in cases of suspected VS was developed. Hemodynamic variables and vasopressor requirements were reviewed for a series of 24 post-CPB patients who received B12a. Favorable changes in hemodynamic parameters and vasopressor requirements were seen after B12a administration although guideline criteria for VS were inconsistently met. These findings support the continued study of B12a in patients with CPB-associated VS.
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 11 条
[1]   Laboratory interferences with the newer cyanide antidote: hydroxocobalamin [J].
Beckerman, Nathan ;
Leikin, Scott M. ;
Aitchinson, Robert ;
Yen, May ;
Wills, Brandon K. .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2009, 26 (01) :49-52
[2]   High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm [J].
Cheungpasitporn, Wisit ;
Hui, John ;
Kashani, Kianoush B. ;
Wittwer, Erica D. ;
Albright, Robert C., Jr. ;
Dillon, John J. .
CLINICAL KIDNEY JOURNAL, 2017, 10 (03) :357-362
[3]  
DesLauriers Carol Ann, 2006, Am J Ther, V13, P161, DOI 10.1097/01.mjt.0000174349.89671.8c
[4]   Vasoplegia During Cardiac Surgery: Current Concepts and Management [J].
Fischer, Gregory W. ;
Levin, Mathew A. .
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2010, 22 (02) :140-144
[5]   Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile [J].
Gerth, Klaus ;
Ehring, Thomas ;
Braendle, Marian ;
Schelling, Pierre .
CLINICAL TOXICOLOGY, 2006, 44 :29-36
[6]  
Lenglet S, 2011, EXPERT REV CARDIOVAS, V9, P1519, DOI [10.1586/erc.11.160, 10.1586/ERC.11.160]
[7]   NITRIC-OXIDE AND ITS ROLE IN THE CARDIOVASCULAR-SYSTEM [J].
LOSCALZO, J ;
WELCH, G .
PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (02) :87-104
[8]  
Ng BKW, 2010, PSYCHOSOMATICS, V51, P194, DOI 10.1176/appi.psy.51.3.194
[9]   Cellular and Molecular Actions of Methylene Blue in the Nervous System [J].
Oz, Murat ;
Lorke, Dietrich E. ;
Hasan, Mohammed ;
Petroianu, George A. .
MEDICINAL RESEARCH REVIEWS, 2011, 31 (01) :93-117
[10]   The Use of High-Dose Hydroxocobalamin for Vasoplegic Syndrome [J].
Roderique, Joseph D. ;
VanDyck, Kofi ;
Holman, Brita ;
Tang, Daniel ;
Chui, Betty ;
Spiess, Bruce D. .
ANNALS OF THORACIC SURGERY, 2014, 97 (05) :1785-1786